Towards SARS-CoV-2 serotypes?

The magnitude of immune evasion of Omicron raises the question whether it should be considered as a distinct SARS-CoV-2 serotype. Here, we discuss lines of evidence in support or against the concept of SARS-CoV-2 serotypes, and the implications of this classification.

Detalles Bibliográficos
Autores principales: Simon-Loriere, Etienne, Schwartz, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855751/
https://www.ncbi.nlm.nih.gov/pubmed/35181769
http://dx.doi.org/10.1038/s41579-022-00708-x
_version_ 1784653713698193408
author Simon-Loriere, Etienne
Schwartz, Olivier
author_facet Simon-Loriere, Etienne
Schwartz, Olivier
author_sort Simon-Loriere, Etienne
collection PubMed
description The magnitude of immune evasion of Omicron raises the question whether it should be considered as a distinct SARS-CoV-2 serotype. Here, we discuss lines of evidence in support or against the concept of SARS-CoV-2 serotypes, and the implications of this classification.
format Online
Article
Text
id pubmed-8855751
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-88557512022-02-18 Towards SARS-CoV-2 serotypes? Simon-Loriere, Etienne Schwartz, Olivier Nat Rev Microbiol Comment The magnitude of immune evasion of Omicron raises the question whether it should be considered as a distinct SARS-CoV-2 serotype. Here, we discuss lines of evidence in support or against the concept of SARS-CoV-2 serotypes, and the implications of this classification. Nature Publishing Group UK 2022-02-18 2022 /pmc/articles/PMC8855751/ /pubmed/35181769 http://dx.doi.org/10.1038/s41579-022-00708-x Text en © Springer Nature Limited 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Comment
Simon-Loriere, Etienne
Schwartz, Olivier
Towards SARS-CoV-2 serotypes?
title Towards SARS-CoV-2 serotypes?
title_full Towards SARS-CoV-2 serotypes?
title_fullStr Towards SARS-CoV-2 serotypes?
title_full_unstemmed Towards SARS-CoV-2 serotypes?
title_short Towards SARS-CoV-2 serotypes?
title_sort towards sars-cov-2 serotypes?
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855751/
https://www.ncbi.nlm.nih.gov/pubmed/35181769
http://dx.doi.org/10.1038/s41579-022-00708-x
work_keys_str_mv AT simonloriereetienne towardssarscov2serotypes
AT schwartzolivier towardssarscov2serotypes

Ejemplares similares